special immunobiologicals’ schedule applied to infants at a reference service in ceará -
Clicks: 116
ID: 204524
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
116 views
25 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #103 of 130 articles by views in food research
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 130 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objective: To analyze the vaccine schedule for preterm infants in a program of special immunobiologicals. Methods: A documental study conducted at a Reference Center of
Special Immunobiologicals (CREATE) situated in a general hospital of tertiary care in pediatrics. The sample consisted of 112 newborns with gestational age below 37 weeks and
weighing less than 2500g, suitable for vaccination, assisted in 2006-2007. Data collection was done from registration forms, reference records and registers of control of special
immunobiologicals’ administration, in year 2008. Results: The results showed that 22 (20%) newborns were weighing between 1000 and 1499g. Regarding gestational age, 39 (35%)
were born between 30 and 34 weeks of pregnancy. Most proceeded from public institutions, 37 (69%). The vaccination schedule of most children, 68 (61%), was incomplete. The main
clinical indications for special immunobiologicals were prematurity and bronchopulmonary dysplasia. It was observed that 89% (n = 100) of preterm infants received the pneumococcal vaccine (Prevenar). For preterm infants who were at risk of developing serious events related to the tetravalent vaccine, it was elected the scheme Prevenar + DTPa + Hib. Simultaneous administration of meningococcal conjugate vaccines - C (MncC) with Prevenar was indicated
for candidates for cochlear implants. Conclusion: The integral care to the preterm newborn involves early immunization, that is, the one that starts in the neonatal unit, and requires the
inclusion of special immunobiologicals, which should be criteriously recommended.
| Reference Key |
oliveira2012revistaspecial
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Vera Lúcia Bezerra Oliveira;Gisele Nogueira de Moura;Joselany Áfio Caetano |
| Journal | food research |
| Year | 2012 |
| DOI |
10.5020/2014
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.